Cart
sales@molnova.com
ROC-325
CAS No. 1859141-26-6
ROC-325 ( ROC 325;ROC325 )
Catalog No. M12869 CAS No. 1859141-26-6
ROC-325 (ROC 325, ROC325) is a novel, orally available inhibitor of lysosomal-mediated autophagy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 61 | Get Quote |
|
| 5MG | 87 | Get Quote |
|
| 10MG | 150 | Get Quote |
|
| 25MG | 303 | Get Quote |
|
| 50MG | 492 | Get Quote |
|
| 100MG | 710 | Get Quote |
|
| 500MG | 1467 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameROC-325
-
NoteResearch use only, not for human use.
-
Brief DescriptionROC-325 (ROC 325, ROC325) is a novel, orally available inhibitor of lysosomal-mediated autophagy.
-
DescriptionROC-325 (ROC 325, ROC325) is a novel, orally available inhibitor of lysosomal-mediated autophagy; exhibits superior in vitro anticancer effects compared with the existing autophagy inhibitor hydroxychloroquine (HCQ) in different cancer cell lines, including accumulation of autophagosomes with undegraded cargo, lysosomal deacidification, p62 stabilization, and disruption of autophagic flux; antagonizes RCC growth and survival in an ATG5/7-dependent manner, induces apoptosis and exhibited favorable selectivity; significantly more effective at inhibiting tumor progression than HCQ, and inhibited autophagy in vivo.
-
SynonymsROC 325;ROC325
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1859141-26-6
-
Formula Weight503.06
-
Molecular FormulaC28H27ClN4OS
-
Purity>98% (HPLC)
-
SolubilityDMSO : 32 mg/mL 63.61 mM; H2O : < 0.1 mg/mL
-
SMILESO=C1C2=C(C(C)=CC=C2NCCN(C)CCNC3=C(C=CC(Cl)=C4)C4=NC=C3)SC5=CC=CC=C51
-
Chemical Name1-((2-((2-((7-chloroquinolin-4-yl)amino)ethyl)(methyl)amino)ethyl)amino)-4-methyl-9H-thioxanthen-9-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Carew JS, et al. Clin Cancer Res. 2017 Jun 1;23(11):2869-2879.
2. Carew JS, et al. Autophagy. 2017 Apr 3;13(4):765-766.
2. Carew JS, et al. Autophagy. 2017 Apr 3;13(4):765-766.
molnova catalog
related products
-
Lys05
Lys05 (Lys01 trihydrochloride, PS-1001)is the water-soluble salt of Lys01, is a 10-fold more potent lysosomal autophagy inhibitor than hydroxychloroquine (HCQ); shows IC50 values of 3.6, 3.8, 6 and 7.9 uM for 1205Lu, c8161, LN229 and HT-29 cell line in the MTT assay.
-
DC661
DC661 (DC-661) is a novel dimeric chloroquine (CQ) that is capable of deacidifying the lysosome and inhibiting autophagy significantly better than HCQ, targets palmitoyl-protein thioesterase 1 (PPT1).
-
XRK3F2
XRK3F2 is a specific ZZ-domain of ubiquitin-binding protein p62 (Sequestosome 1) inhibitor that inhibits MM cell growth and BMSC growth enhancement of human MM cells.
